The FDA has approved a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the …
Januvia
Victoza: The Earlier The Better, New Study Shows
New data presented at the European Association for the Study of Diabetes (EASD) shows a significantly higher proportion …
Victoza Found More Effective Than Byetta and Januvia In Treatment of Type 2 Diabetes
New data from two extension studies presented by Novo Nordisk at the 71st Annual Scientific Sessions of the American Dia…
Type 2 Diabetes Patients Prefer Injectable Victoza to Oral Januvia
New Patient Reported Outcomes (PRO) data presented by today at the European Association for the Study of Diabetes (EASD)…
All About Victoza: An Interview with Novo Nordisk’s Dr. Alan Moses
Incretin-based treatments target the beta cell and enhance the release of insulin based on the amount of glucose in the …
Victoza Superior to Januvia, New Study Shows
Late-breaking Novo Nordisk extension data presented at the 70th Annual Scientific Sessions of the American Diabetes Asso…
Superior Efficacy of Victoza Compared to Januvia in the Treatment of Type 2 Diabetes
Novo Nordisk's new diabetes drug Victoza proved more effective than Merck & Co's Januvia in a head-to-head study publish…
Phase III Trials Show Roche’s Type 2 Drug Better Than Januvia
The Swiss -based pharmaceuticals and diagnostics company Roche Holding AG announced headline results from the second and…
Januvia (Sitagliptin) has been approved by the European Commission
According to Diabetes UK the European Commission has approved Sitagliptin ,known as Januvia, as an add-on to insulin (wi…
Merck’s Diabetes Drug Januvia Linked to Pancreatitis
The FDA announced yesterday that it has received 88 reports of pancreatitis (inflammation of the pancreas) in patients t…
